This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

AboutAboutEnbrel commitment to inflammation careDosingDosingEnbrel dosing and administrationMyClic pre-filled penPre-filled syringeMyClic administrationPowder and solventEfficacy and SafetyEfficacy and SafetyEnbrel therapeutic indicationsRheumatoid arthritisJuvenile idiopathic arthritisPsoriatic arthritis
Ankylosing spondylitisPlaque psoriasis
Support & ResourcesSupport & ResourcesEnbrel patient supportOrder patient materialsEnbrel: Sleeve for MyClic pre-filled pensVideosMaterials

Information on how to access Enbrel® (etanercept) and Maxtrex (methotrexate) prescribing information and adverse event reporting can be found at the bottom of the page.

Enbrel® MyClic Pre-Filled Pen

The MyClic pre-filled pen is a simple administration device containing 25 mg or 50 mg of Enbrel. Benefits of MyClic include higher patient adherence, satisfaction and convenience, and increased ease of use, compared with a pre-filled syringe.1

Enbrel Injectable Pen: Simple | Sure | Secure2,3MyClic: Flexible dosing options, with 25 mg strength

Only Enbrel offers the range of administration and dosing options with 10 mg (paediatric), 25 mg and 50 mg strengths available.3-6 MyClic offers increased flexibility to choose the preferred delivery method for all patient types.5

MyClic: Proven patient benefits1

33% of UK RA patients say that their HCPs underestimate the pain and discomfort of injected medications.7

Among Enbrel patients who had previously used a pre-filled syringe, the MyClic pre-filled pen was associated with:

  • Higher patient satisfaction compared to the pre-filled syringe, including easiness of learning how to use the device (p<0.001) and performing the injection (p<0.001)*8
  • Significantly reduced pain at the injection site: mean VAS score 2.91 vs. 1.77 (p<0.001)†2
  • An adherence level of >95%2
  • An increase from 66% to 93% in patients self-administering Enbrel2
  • A decrease from 23% to 2% in patients requiring nurse assistance in primary care facilities2

MyClic does not interfere with patients’ social lives, leisure and daily activities1

​​​​​​​*In a multi-centre, open-label, randomised, parallel-design study, 421 adult patients with psoriasis were randomised to receive Enbrel 50 mg twice weekly subcutaneously for 12 weeks either as a pre-filled syringe or as a pre-filled pen. The primary outcome was patient satisfaction at week 12 with the injection device as measured on a 0–10 point Likert scale. The study was powered to demonstrate non-inferiority of a pen over a syringe for the primary endpoint.8​​​​​​​

38 men and 66 women diagnosed with rheumatoid arthritis (56%), psoriatic arthritis (30%) and ankylosing spondylitis (14%) switched from the 50 mg pre-filled syringe to the 50 mg MyClic pre-filled pen. Patients answered questions during an interview 2 months after starting Enbrel treatment with the MyClic pre-filled pen.2

Explore more Enbrel dosing and administration

Learn more about the dosing and administration of Enbrel, across indications.

MyClic administration Loading
Enbrel patient support

See what online support your patients have access to

Find out more Loading

HCP=healthcare professional; JIA=juvenile idiopathic arthritis; RA=rheumatoid arthritis.

Prescribing information

Enbrel (etanercept) prescribing information,  Enbrel PI
Maxtrex (methotrexate) prescribing information, Maxtrex PI 

 

To return to the homepage click Enbrel (etanercept)

References

Müller-Ladner U, et al. Z Rheumatol. 2012;71:890-899.Borrás-Blasco J, et al. Expert Opin Biol Ther. 2013;13:1103-1108.Enbrel (etanercept) SmPC. 50 mg solution for injection in pre-filled pen. Enbrel (etanercept) SmPC. 25 mg powder and solvent for solution for injection. Enbrel (etanercept) SmPC. 25 mg solution for injection in pre-filled syringe.Enbrel (etanercept) SmPC 10 mg solution for injection.Pfizer Data on file. RA NarRAtive Patient Survey Banner.Paul C, et al. J Eur Acad Dermatol Venereol. 2012;26:448-455.
PP-ENB-GBR-1132. January 2023
Watch a video on how to admisiter Enbrel with the MyClic pen Watch now Loading

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​